For example, in colorectal adenocarcinomas, eight studies linked high CEA expression to unfavorable tumor features and/or prognosis while six studies found no association between CEA immunostaining and tumor phenotype and/or prognosis (Supplementary Table S4). This evidence concerns the gene CEACAM5 and neoplasm.